Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Nature and Prevalence of Glucocorticoid-related Morbidity in Patients With Autoimmune Bullous Disease (AIBD) Using the Glucocorticoid Toxicity Index (GTI)

NCT05525065 is registered in ClinicalTrials.gov with Premier Specialists, Australia as lead sponsor.

NCT NCT05525065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05525065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Nature and Prevalence of Glucocorticoid-related Morbidity in Patients With Autoimmune Bullous Disease (AIBD) Using the Glucocorticoid Toxicity Index (GTI)
Lead sponsor
Premier Specialists, Australia
Phase
Observational
Overall status
Unknown status
Start date
February 2, 2019
Completion date
September 1, 2025
Enrollment
138 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune bullous dermatosis, glucocorticoids toxicity